Loading clinical trials...
Loading clinical trials...
A Phase II Study of Weekly Maintenance Bortezomib and Rituximab in Mantle Cell Lymphoma Post Autologous Hematopoietic Cell Transplantation
Conditions
Interventions
bortezomib
rituximab
+8 more
Locations
2
United States
City of Hope Medical Center
Duarte, California, United States
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
October 3, 2011
Primary Completion Date
November 2, 2020
Completion Date
November 2, 2020
Last Updated
July 27, 2023
NCT04054167
NCT06839053
NCT06859008
NCT02153580
NCT01815749
NCT03015896
Lead Sponsor
City of Hope Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions